I'm putting DVAX on the radar for Monday. Price shot up after hours on Friday after FDA advisory panel voted in favor of their Hep B vaccine. http://www.nasdaq.com/article/data-supports-safety-of-dynavax-hepatitis-b-vaccine-u.s.-fda-panel-20170728-01088 Looks like final decision may come out the week of Aug 7.